The current study shows that psoriasis patients have distinctive temperament and character dimensions when compared with the control group. We suggest that evaluation and treatment of psoriasis should also include psychosomatic approaches in clinical practice.

Avoidant/restrictive food intake disorder (ARFID) is a new diagnostic category in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) which replaces and extends the DSM-4 diagnosis of feeding disorder of infancy or early childhood. There is limited information as to the characteristics of the patients with ARFID, its course and prognosis and treatment. We aim to contribute to available literature on ARFID by presenting this case. We discussed a young lady with ARFID who responded well to cognitive behavioral therapy (CBT) with successful application of in vivo exposure, systematic desensitization, and cognitive restructuring techniques. After the 12 sessions of CBT as inpatient and eight sessions as outpatient, she gained 4 kg (8.81 lbs); her body mass index (BMI) rising from 16 to 17.5 kg/m 2 , Hamilton anxiety rating score dropped from 27 to 5. She continued to improve reaching the BMI of 18.3 kg/m 2 6-month post-discharge. This case suggests that CBT can be a useful treatment modality in adults with ARFID.

No abstract

BackgroundThe concept of facial emotion recognition is well established in various neuropsychiatric disorders. Although emotional disturbances are strongly associated with somatoform disorders, there are a restricted number of studies that have investigated facial emotion recognition in somatoform disorders. Furthermore, there have been no studies that have regarded this issue using the new diagnostic criteria for somatoform disorders as somatic symptoms and related disorders (SSD). In this study, we aimed to compare the factors of facial emotion recognition between patients with SSD and age- and sex-matched healthy controls (HC) and to retest and investigate the factors of facial emotion recognition using the new criteria for SSD.Patients and methodsAfter applying the inclusion and exclusion criteria, 54 patients who were diagnosed with SSD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and 46 age- and sex-matched HC were selected to participate in the present study. Facial emotion recognition, alexithymia, and the status of anxiety and depression were compared between the groups.ResultsPatients with SSD had significantly decreased scores of facial emotion for fear faces, disgust faces, and neutral faces compared with age- and sex-matched HC (t=−2.88, P=0.005; t=−2.86, P=0.005; and t=−2.56, P=0.009, respectively). After eliminating the effects of alexithymia and depressive and anxious states, the groups were found to be similar in terms of their responses to facial emotion and mean reaction time to facial emotions.DiscussionAlthough there have been limited numbers of studies that have examined the recognition of facial emotion in patients with somatoform disorders, our study is the first to investigate facial recognition in patients with SSD diagnosed according to the DSM-5 criteria. Recognition of facial emotion was found to be disturbed in patients with SSD. However, our findings suggest that disturbances in facial recognition were significantly associated with alexithymia and the status of depression and anxiety, which is consistent with the previous studies. Further studies are needed to highlight the associations between facial emotion recognition and SSD.

No abstract